Zusammenfassung
Muskeldystrophien sind eine klinisch und pathogenetisch heterogene Gruppe progressiver Muskelerkrankungen, die zu einer primären Degeneration von Muskelfasern führen. Das Manifestationsalter reicht von der frühen Kindheit bis in das späte Erwachsenenalter. Bei vielen Formen ist der zugrunde liegende Gendefekt bekannt, und es erfolgt eine genetische Klassifikation. Auch die kongenitalen Myopathien, die bereits kurz nach der Geburt klinisch manifest werden, stellen mittlerweile eine große Gruppe von Myopathien dar.
Similar content being viewed by others
Literatur
Blumen SC, Bouchard JP, Brais B et al (2009) Cognitive impairment and reduced life span of oculopharyngeal muscular dystrophy homozygotes. Neurology 73:596–601
Bonifati MD, Ruzza G, Bonometto P, Berardinelli A, Gorni K, Orcesi S, Lanzi G, Angelini C (2000) A multicenter, double-blind, randomized, trial of deflazacort versus prednisone in Duchenne muscular dystrophy. Muscle Nerve 23:1344–1347
Brais B, Bouchard JP, Xie YG et al (1998) Short GCG expansion in the PABP2 gene cause oculopharyngeal muscular dystrophy. Nat Genet 18:164–167
Bushby K, Finkel R, Birnkrant DJ et al (2010a) Diagnosis and management of Duchenne muscular dystrophy, part 1: diagnosis, and pharmacological and psychosocial management. Lancet Neurol 9:77–93
Bushby K, Finkel R, Birnkrant DJ et al (2010b) Diagnosis and management of Duchenne muscular dystrophy, part 2: implementation of multidisciplinary care. Lancet Neurol 9:177–189
Davies JE, Wang L, Garcia-Oroz L et al (2005) Doxycycline attenuates and delays toxicity of the oculopharyngeal muscular dystrophy mutation in transgenic mice. Nat Med 11:672–677
Davies JE, Sarkar S, Rubinsztein DC (2006) Trehalose reduces aggregate formation and delays pathology in a transgenic mouse model of oculopharyngeal muscular dystrophy. Hum Mol Genet 15:23–31
De Sandre-Giovannoli A, Chaouch M, Kozlov S et al (2002) Homozygous defects in LMNA, encoding lamin A/C nuclear-envelope proteins, cause autosomal recessive axonal neuropathy in human (Charcot–Marie–Tooth disorder type 2) and mouse. Am J Hum Genet 70:726–736
Deschauer M, Pushpa RJ, Gläser D, Hanisch F, Stoltenburg G, Zierz S (2011) Klinische und molekulargenetische Befunde der Muskeldystrophie mit Anoctamin 5-Mutationen. Nervenarzt 82:1596–1603
Eger K, Jordan B, Habermann S, Zierz S (2010) Beevor’s sign in facioscapulohumeral muscular dystrophy: an old sign with new implications. J Neurol 257:436–438
Feit H, Silbergleit A, Schneider L et al (1998) Vocal cord and pharyngeal weakness with autosomal distal myopathy: clinical description and gene localization to chromosome 5q31. Am J Hum Genet 63:1732–1744
Fischer D, Walter MC, Kesper K et al (2005) Diagnostic value ot muscle MRI in differentiating LGMD2I from other LGMDs. J Neurol 252:538–547
Gaul C, Deschauer M, Tempelmann C et al (2006) Cardiac involvement in limb-girdle muscular dystrophy 2I (LGMD2I) – conventional cardiac diagnostic and cardiovascular magnetic resonance (CMR. J Neurol 253:1317–1322
Guglieri M, Straub V, Bushby K, Lochmüller H (2008) Limb-girdle muscular dystrophies. Curr Opin Neurol 21:576–584
Hackman P, Vihola A, Haravuori H, Marchand S, Sarparanta J, De Seze J, Labeit S, Witt C, Peltonen L, Richard I, Udd B (2002) Tibial muscular dystrophy is a titinopathy caused by mutations in TTN, the gene encoding the giant skeletal-muscle protein titin. Am J Hum Genet 71:492–500
Hanisch F, Grimm D, Zierz S, Deschauer M (2010) Frequency of the FKRP mutation c.826C>A in isolated hyperCKemia and limb girdle muscular dystrophy type 2 in German patients. J Neurol 257:300–301
Hassan A, Jones LK, Milone M, Kumar N (2012) Focal and other unusual presentations of facioscapulohumeral muscular dystrophy. Muscle Nerve 46:421–425
Hicks D, Sarkozy A, Muelas N et al (2011) A founder mutation in Anoctamin 5 is a major cause of limb-girdle muscular dystrophy. Brain 134:171–182
Illa I, Serrano-Munuera C, Gallardo E, Lasa A, Rojas-Garcia R, Palmer J, Gallano P, Baiget M, Matsuda C, Brown RH Jr (2001) Distal anterior compartment myopathy: a dysferlin mutation causing a new muscular dystrophy phenotype. Ann Neurol 49:130–134
Krasnianski M, Neudecker S, Eger K, Schulte-Mattler W, Zierz S (2003a) Facioscapulohumeral muscular dystrophy. The spectrum of clinical manifestations and molecular genetic changes. Nervenarzt 74:151–158
Krasnianski M, Neudecker S, Eger K, Jakubiczka S, Zierz S (2003b) Atypical phenotypes in patients with FSHD 4q35 deletion. Arch Neurol 60:1421–1425
Kuhn M, Gläser D, Joshi PR, Zierz S, Wenninger S, Schoser B, Deschauer M (2016) Utility of a next-generation sequencing-based gene panel investigation in German patients with genetically unclassified limb-girdle muscular dystrophy. J Neurol 263:743–750
Larsen M, Rost S, Kress W, El Hajj N, Ferbert A, Deschauer M, Walter MC, Tacik P, Müller CR (2015) Diagnostic approach for FSHD revisited: SMCHD1 mutations cause FSHD2 and act as modifiers of disease severity in FSHD1. Eur J Hum Genet 23:808–816
Lemmers RJ, van der VP, Klooster R et al (2010) A unifying genetic model for facioscapulohumeral muscular dystrophy. Science 329:1650–1653
Lemmers RJ, O’Shea S, Padberg GW et al (2012a) Best practice guidelines in genetic diagnostics of facioscapulohumeral muscular dystrophy. Neuromuscul Disord 22:463–470
Lemmers RJ, Tawil R, Petek LM et al (2012b) Digenic inhetiance o fan SMCHD1 mutation and an FSHD-permissive D4Z4 allele causes facioscapulohumeral muscular dystrophy type 2. Nat Genet 44:1370–1374
Liang WC, Mitsuhashi H, Keduka E, Nonaka I, Noguchi S, Nishino I, Hayashi YK (2011) TMEM43 mutations in Emery-Dreifuss muscular dystrophy-related myopathy. Ann Neurol 69(6):1005–1013
Liu J, Aoki M, Illa I, Wu C, Fardeau M, Angelini C, Serrano C, Urtizberea JA, Hentati F, Hamida MB, Bohlega S, Culper EJ, Amato AA, Bossie K, Oeltjen J, Bejaoui K, McKenna-Yasek D, Hosler BA, Schurr E, Arahata K, de Jong PJ, Brown RH Jr (1998) Dysferlin, a novel skeletal muscle gene, is mutated in Miyoshi myopathy and limb girdle muscular dystrophy. Nat Genet 20:31–36
Markesbery WR, Griggs RC, Leach RP, Lapham LW (1974) Related articles. Late onset hereditary distal myopathy. Neurology 24:127–134
Meredith C, Herrmann R, Parry C et al (2004) Mutations in the slow skeletal muscle fiber myosin heavy chain gene (MYH7) cause laing early-onset distal myopathy (MPD1). Am J Hum Genet 75:703–708
Merideth MA, Gordon LB, Clauss S et al (2008) Phenotype and course of Hutchinson-Gilford progeria syndrome. N Engl J Med 358:592–604
Mueller TJ, Kraya T, Stoltenburg G, Stock K, Deschauer M, Zierz S (2010) Matrin3-myopathy: distal and axial myopathy without vocal cord involvement. Clin Neurophysiol 121(Suppl 1):S306–S307
Müller T, Schröder R, Zierz S (2001) GCG repeats and phenotype in oculopharyngeal muscular dystrophy. Muscle Nerve 24:120–122
Müller T, Krasnianski M, Witthaut R, Deschauer M, Zierz S (2005) Dilated cardiomyopathy may be an early sign of the C826A Fukutin-related protein mutation. Neuromuscul Disord 15:372–376
Müller T, Deschauer M, Kolbe-Fehr F, Zierz S (2006) Genetic heterogeneity in 30 German patients with oculopharyngeal muscular dystrophy. J Neurol 253:892–895
Nguyen K, Bassez G, Krahn M et al (2007) Phenotypic study in 40 patients with dysferlin gene mutations: high frequency of atypical phenotypes. Arch Neurol 64:1176–1182
Nigro V, Savarese M (2014) Genetic basis of limb-girdle muscular dystrophies: the 2014 update. Acta Myol 33:1–12
Nonaka I, Sunohara N, Ishiura S, Satoyoshi E (1981) Familial distal myopathy with rimmed vacuoles and lamellar (myeloid) body formation. J Neurol Sci 51:141–151
Norwood F, de Visser M, Eymard B, EFNS Guideline Task Force et al (2007) EFNS guideline on diagnosis and management of limb girdle muscular dystrophies. Eur J Neurol 14:1305–1312
Norwood FL, Harling C, Chinnery PF, Eagle M, Bushby K, Straub V (2009) Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain 132:3175–3186
Quijano-Roy S, Mbieleu B, Bonnemann CG et al (2008) De novo LMNA mutations cause a new form of congenital muscular dystrophy. Ann Neurol 64:177–186
Sarkozy A, Deschauer M, Schrank B et al (2012) Muscle MRI findings in limb girdle muscular dystrophy type 2L. Neuromuscul Disord 22:S122–S129
Selcen D, Engel AG (2005) Mutations in ZASP define a novel form of muscular dystrophy in humans. Ann Neurol 57:269–276
Senderek J, Garvey SM, Krieger M, Guergueltcheva V, Urtizberea A, Roos A, Elbracht M, Stendel C, Tournev I, Mihailova V, Feit H, Tramonte J, Hedera P, Crooks K, Bergmann C, Rudnik-Schöneborn S, Zerres K, Lochmüller H, Seboun E, Weis J, Beckmann JS, Hauser MA, Jackson CE (2009) Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am J Hum Genet 84:511–518
Tomimitsu H, Shimizu J, Ishikawa K, Ohkoshi N, Kanazawa I, Mizusawa H (2004) Distal myopathy with rimmed vacuoles (DMRV): new GNE mutations and splice variant. Neurology 62:1607–1610
Udd B (2007) Molecular biology of distal muscular dystrophies – sarcomeric proteins on top. Biochim Biophys Acta 1772:145–158
Udd B, Kaarianen H, Somer H (1991) Muscular dystrophy with separate clinical phenotypes in a large family. Muscle Nerve 14:1050–1058
Udd B, Partanen J, Halonen P, Falck B, Hakamies L, Heikkila H, Ingo S, Kalimo H, Kaariainen H, Laulumaa V et al (1993) Tibial muscular dystrophy. Late adult-onset distal myopathy in 66 Finnish patients. Arch Neurol 50:604–608
Udd B, Vihola A, Sarparanta J, Richard I, Hackman P (2005) Related articles. Titinopathies and extension of the M-line mutation phenotype beyond distal myopathy and LGMD2J. Neurology 64:636–642
Vissing J (2016) Limb girdle muscular dystrophies: classification, clinical spectrum and emerging therapies. Curr Opin Neurol 29:635–641
Walter MC, Petersen JA, Stucka R et al (2004) FKRP (826C>A) frequently causes limb-girdle muscular dystrophy in German patients. J Med Genet 41:e50
Walter MC, Reilich P, Thiele S, Schessl J, Schreiber H, Reiners K, Kress W, Müller-Reible C, Vorgerd M, Urban P, Schrank B, Deschauer M, Schlotter-Weigel B, Kohnen R, Lochmüller H (2013) Treatment of dysferlinopathy with deflazacort: a double-blind, placebo-controlled clinical trial. Orphanet J Rare Dis 8:26
Wang CH, Leung M, Liang WC et al (2012) Correlation between muscle involvement, phenotype and D4Z4 fragment size in facioscapulohumeral muscular dystrophy. Neuromuscul Disord 22:331–338
Zierz SF (2013) Muskelerkrankungen. Thieme, Stuttgart/New York
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer-Verlag GmbH Deutschland
About this entry
Cite this entry
Kraya, T., Deschauer, M., Zierz, S. (2018). Progressive Muskeldystrophien und kongenitale Myopathien. In: Berlit, P. (eds) Klinische Neurologie. Springer Reference Medizin. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-44768-0_34-1
Download citation
DOI: https://doi.org/10.1007/978-3-662-44768-0_34-1
Received:
Accepted:
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-44768-0
Online ISBN: 978-3-662-44768-0
eBook Packages: Springer Referenz Medizin